Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
688505
Company Profile
Business description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Contact
308 Cailun Road
Zhangjiang Hi-Tech Park
Pudong
Shanghai201210
CHNT: +86 2158953355
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
899
Stocks News & Analysis
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,135.90 | 19.50 | -0.21% |
CAC 40 | 7,857.38 | 23.49 | -0.30% |
DAX 40 | 23,774.57 | 29.51 | 0.12% |
Dow JONES (US) | 46,316.07 | 68.78 | 0.15% |
FTSE 100 | 9,316.80 | 16.96 | 0.18% |
HKSE | 26,855.56 | 232.68 | 0.87% |
NASDAQ | 22,591.15 | 107.09 | 0.48% |
Nikkei 225 | 44,932.63 | 111.12 | -0.25% |
NZX 50 Index | 13,292.36 | 159.80 | 1.22% |
S&P 500 | 6,661.21 | 17.51 | 0.26% |
S&P/ASX 200 | 8,848.80 | 20.50 | -0.23% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |